期刊文献+

黏蛋白型O-聚糖:结构、功能及与肿瘤的相关性 被引量:9

Mucin-type O-glycans in human cancer:structures and functions
原文传递
导出
摘要 黏蛋白是细胞表面的或分泌的、具有高度O-糖基化修饰的糖蛋白。黏蛋白型O-聚糖是由多肽:N-乙酰氨基半乳糖转移酶(ppGalNAc-T)家族催化起始合成的,在肿瘤中常常伴随着黏蛋白型O-聚糖结构和数量上的改变,形成肿瘤特异聚糖结构(cancer-associated glycans),如肿瘤Tn和T抗原等。肿瘤特异聚糖使肿瘤细胞的抗原性和黏附能力发生改变,促进肿瘤细胞的恶性增生与转移。而这些肿瘤特异聚糖结构,也为肿瘤的诊断与抗肿瘤药物或疫苗开发提供了理论基础。 Mucins are heavily O-glycosylated glycoproteins found in mucous secretions and as transmembrane glycoproteins of the cell surface with the glycan exposed to the external environment.In mucins,O-glycans are covalently α-linked via an N-acetylgalactosamine(GalNAc)moiety to serine or threonine,and the structures are named mucin-type O-glycans.Mucin-type O-glycans are initiated by UDP-GalNAc: polypeptide N-Acetylgalactosa minyltransferases,which enzymatic mechanism and structural features have been a hot topic of glycosyltransferases research.Mucin-type O-glycans of cancer cells are often changed,both in structure and in quantity,developing several cancer-associated glycans,such as T and Tn antigens.These structural changes can alter the function of the cancer cells,and its antigenic and adhesive properties,as well as its potential to invade and metastasize.These cancer-associated glycans can be exploited to tumor diagnosis,and in the development of anti-tumor drug or vaccine.
作者 吴士良
出处 《生命科学》 CSCD 北大核心 2011年第6期563-568,共6页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(30670462)
关键词 糖基化 O型聚糖 肿瘤特异聚糖 T和Tn抗原 肿瘤细胞 glycosylation O-glycan cancer-associated glycan T and Tn antigen cancer cell
  • 相关文献

参考文献23

  • 1Hollingsworth MA, Swanson BJ. Mucins in cancer:protection and control of the cell surface. Nat Rev Cancer,2004,4(1):45-60.
  • 2Ju T, Brewer K, D'Souza A, et al. Cloning and expressionof human core 1 β1, 3-galactosyltransferase. J Biol Chem,2002, 277(1): 178-186.
  • 3Narimatsu Y, Ikehara Y, Iwasaki H, et al. Immunocytochemiealanalysis for intracellular dynamics of C1GalT associatedwith molecular chaperone, Cosmc. Biochem Biophys ResCommun, 2008, 366(1): 199-205.
  • 4Ju T, Cummings RD. Protein glycosylation: chaperonemutation in Tn syndrome. Nature, 2005, 437(7063): 1252.
  • 5Schietinger A, Philip M, Yoshida BA, et al. A mutantchaperone converts a wild-type protein into a tumor-specific antigen. Science, 2006, 314(5797): 304-8.
  • 6Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta, 1999, 1473(1): 67-95.
  • 7Fukuda M. Roles ofmucin-type O-glycans synthesized by core2β1, 6-N-acetylglucosaminyltransferase. Methods Enzymol, 2006, 416:332-46.
  • 8Tsuiji H, Takasaki S, Sakamoto M, et al. AberrantO-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates celicell±adhesion. Glycobiology, 2003, 13(7): 521-7.
  • 9Schneider F, Kemmner W, Haensch W, et al. Overexpression of sialyltransferase CMP-sialic acid: Galbl, 3GalNAc-Ra6-sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res, 2001, 61: 4605-11.
  • 10Meichenin M, Rocher J, Galanina O, et al. Tk, a new colon tumor-associated antigen resulting from altered O-glycosylation. Cancer Res, 2000, 60:5499-507.

同被引文献78

  • 1隋芳,石林,杨振,侯鹏.长链非编码RNA在甲状腺癌中的研究进展[J].肿瘤,2022,42(1):53-64. 被引量:2
  • 2刘春亮,吴士良.黏蛋白型O-聚糖在人类肿瘤中的结构异常及生物学功能[J].生物化学与生物物理进展,2010,37(5):475-483. 被引量:7
  • 3李烨,王永丽,贺国平.基于支持向量机的结肠癌信息基因提取[J].山东科技大学学报(自然科学版),2012,31(3):84-89. 被引量:3
  • 4代智,刘银坤.糖基转移酶与肝癌发生[J].国外医学(肿瘤学分册),2005,32(2):144-146. 被引量:5
  • 5周嘉梁,黄超群,吴士良,孙其昌,雷伟,金美芳,姜智,沈宏杰.人类新型β3半乳糖基转移酶基因β3GalT7的克隆和鉴定[J].生物化学与生物物理进展,2005,32(2):140-146. 被引量:3
  • 6BROCKHAUSEN I. Pathways of O-glycan biosynthesis in can- cer cell[J]. Biochimica et Biophysica Acta, 1999, 1473(1): 67-95.
  • 7MAKOTO I. JOJi K, HIROSHI Net et al . The expression pattern of UDP-N-Acetyl-a-D-Galaetosamine: polypeptide N-Acelyl- galactosaminyl transferase-3 in early gastrie carcinomalJ]. Jour- nal of Surgical Oncology, 2004, 86(1): 28-33.
  • 8CHEN W, XIAODAN G, WEINA W, et td. N-Acetylgalac- tosaminyltransferase-14 as a potential biomarker for breast can- cer by immunohistochemistry[J]. BMC Cancer, 2010, 10: 123.
  • 9NORA B, DANIEL M, LUllS U, et al. UDP-N-Acetyl-D-Galac- tosamine: Polypeptide N-Acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker[J]. Journal of ttistochemistrv & Cvtochemistrv. 2006. 54(3): 317-328.
  • 10GU C, OYAMA T,'OSAKI T,et td. Low expression of poly- peptide GalNAc N-acetylgalactosaminyl Lransifrase-3 in lung- adenocarcinoma: impact on poor prognosis and early recur- rcnceIJI. British Journal of Cancer, 2004, 90(2): 436-442.

引证文献9

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部